Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study-Reference-Cited by-同舟云学术

Hybrid closed-loop glucose control compared with sensor augmented pump therapy in older adults with type 1 diabetes: an open-label multicentre, multinational, randomised, crossover study

Published:2022-03 Issue:3 Volume:3 Page:e135-e142
ISSN:2666-7568
Container-title:The Lancet Healthy Longevity
language:en
Short-container-title:The Lancet Healthy Longevity

Author:

Boughton Charlotte K,Hartnell Sara,Thabit Hood,Mubita Womba M,Draxlbauer Katharine,Poettler Tina,Wilinska Malgorzata E,Hood Korey K,Mader Julia K,Narendran Parth,Leelarathna Lalantha,Evans Mark L,Hovorka Roman

Funder

National Institute for Health and Care Research

Eli Lilly and Company

Juvenile Diabetes Research Foundation United Kingdom

National Institute of Diabetes and Digestive and Kidney Diseases

Wellcome Trust

Publisher

Elsevier BV

Subject

Family Practice,Psychiatry and Mental health,Geriatrics and Gerontology,Health (social science)

Reference20 articles.

1. Improvements in the life expectancy of type 1 diabetes: the Pittsburgh Epidemiology of Diabetes Complications study cohort;Miller;Diabetes,2012